Health Care Companies By Enterprise Value

Current Valuation
Current ValuationEfficiencyMarket RiskExp Return
1LLY Eli Lilly and
865.27 B
 0.12 
 1.81 
 0.22 
2UNH UnitedHealth Group Incorporated
481.92 B
(0.13)
 2.28 
(0.30)
3ABBV AbbVie Inc
428.36 B
 0.23 
 1.35 
 0.30 
4JNJ Johnson Johnson
410.38 B
 0.16 
 1.19 
 0.19 
5NVO Novo Nordisk AS
406.78 B
(0.09)
 3.40 
(0.31)
6MRK Merck Company
257.23 B
(0.09)
 1.78 
(0.16)
7AZN AstraZeneca PLC ADR
257.15 B
 0.22 
 1.19 
 0.26 
8ABT Abbott Laboratories
245.66 B
 0.24 
 1.32 
 0.31 
9NVS Novartis AG ADR
235.34 B
 0.12 
 1.25 
 0.15 
10TMO Thermo Fisher Scientific
220.59 B
 0.00 
 1.56 
 0.00 
11AMGN Amgen Inc
215.84 B
 0.16 
 1.50 
 0.24 
12ISRG Intuitive Surgical
194.99 B
 0.03 
 1.76 
 0.05 
13PFE Pfizer Inc
192.96 B
 0.03 
 1.35 
 0.04 
14BSX Boston Scientific Corp
163.64 B
 0.20 
 1.18 
 0.24 
15DHR Danaher
162.23 B
(0.09)
 1.74 
(0.15)
16BMY Bristol Myers Squibb
161.84 B
 0.03 
 1.56 
 0.05 
17GILD Gilead Sciences
158.03 B
 0.24 
 1.55 
 0.38 
18SYK Stryker
157.89 B
 0.04 
 1.24 
 0.04 
19CVS CVS Health Corp
152.88 B
 0.09 
 3.09 
 0.27 
20SNY Sanofi ADR
150.95 B
 0.19 
 1.63 
 0.31 
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents. Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.